Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, Australia.
Gastrointest Endosc. 2010 Mar;71(3):589-95. doi: 10.1016/j.gie.2009.10.033.
Succinylated gelatin (SG) is an inexpensive colloid that may combine ease of use with the advantages of a colloid to potentially increase EMR specimen size, leading to a higher rate of en bloc resection.
To evaluate the safety, efficacy, and impact on EMR specimen size of SG as a submucosal (s.m.) injectant in comparison with normal saline solution (NS).
Randomized, blinded, controlled trial conducted with Animal Ethics Committee approval.
Academic hospital.
Ten swine.
Sixty EMRs (30 using SG vs 30 using NS as 3 paired experiments per animal) of the largest possible en bloc snare resection of normal colonic mucosa after s.m. injection of a fixed volume of either SG or NS.
EMR specimen size, duration of s.m. cushion, duration of procedure, ratio of vertical elevation to lateral spread of injectant, ease of resection, adverse effects, perforation, histopathology of EMR sites in colectomy specimens at necropsy (for inflammatory cell content, depth of ulceration, and vascular or ischemic changes).
The mean subject weight was 53 kg. The mean EMR specimen dimensions and surface area were significantly larger with SG (length 37 vs 31 mm, P = .031; width 32 vs 26 mm, P = .022; surface area 9.5 cm(2) vs 6.7 cm(2), P = .044, respectively). The median s.m. cushion duration was 60 minutes with SG versus 15 minutes with NS (P = .005). The median procedure duration with SG was 2.6 minutes vs 2.5 minutes with NS (P = .515). The ratio of vertical elevation to lateral spread of injectant (mean score on a 3-point scale) was 3 with SG versus 2 with NS (P = .228). Ease of resection score (mean score on a 10-point scale) was 8 with SG versus 7 with NS (P = .216). There were no systemic adverse effects, hypersensitivity reactions, or bleeding episodes. There were 2 perforations (treated with clips) with SG and 1 with NS (P = 1.0). Blinded histopathologist assessment of necropsy colectomy specimens did not identify any significant differences between SG and NS EMR sites.
Animal study.
SG is safe and results in a 42% increased surface area for en bloc EMR. Given its other favorable properties, it represents a significant step toward defining the ideal EMR solution.
琥珀酰明胶(SG)是一种廉价的胶体,它可能兼具易用性和胶体的优势,从而有可能增加 EMR 标本的大小,提高整块切除率。
评估 SG 作为黏膜下(s.m.)注射剂与生理盐水(NS)相比的安全性、疗效和对 EMR 标本大小的影响。
随机、双盲、对照临床试验,并获得动物伦理委员会的批准。
学术医院。
10 头猪。
在 s.m. 注射固定体积的 SG 或 NS 后,对最大可能整块圈套切除的正常结肠黏膜进行 60 次 EMR(每头动物进行 3 次配对实验,每次 30 次)。
EMR 标本大小、黏膜下垫持续时间、操作时间、注射剂垂直抬高与侧向扩展的比值、切除难易程度、不良反应、穿孔、尸检时结肠切除术标本 EMR 部位的组织病理学(炎症细胞含量、溃疡深度和血管或缺血变化)。
受试者平均体重为 53 公斤。SG 的 EMR 标本尺寸和表面积明显更大(长度 37 与 31mm,P=0.031;宽度 32 与 26mm,P=0.022;表面积 9.5cm2 与 6.7cm2,P=0.044)。SG 的黏膜下垫持续时间中位数为 60 分钟,而 NS 为 15 分钟(P=0.005)。SG 的操作时间中位数为 2.6 分钟,而 NS 为 2.5 分钟(P=0.515)。注射剂垂直抬高与侧向扩展的比值(3 分制平均分)为 3 分,而 NS 为 2 分(P=0.228)。切除难易程度评分(10 分制平均分)为 8 分,而 NS 为 7 分(P=0.216)。SG 有 2 例穿孔(用夹处理),而 NS 有 1 例穿孔(P=1.0)。盲法病理学家对尸检结肠切除术标本的评估未发现 SG 和 NS EMR 部位之间有任何显著差异。
动物研究。
SG 是安全的,整块 EMR 的表面积增加了 42%。鉴于其其他有利特性,它代表了朝着定义理想 EMR 溶液迈出的重要一步。